Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - OPERATING INCOME
Operating Income KROS - Keros Therapeutics, Inc.
-170 M
LAST VALUE
-73.63%
2 YEAR CAGR
-151.44%
5 YEAR CAGR
0.00%
10 YEAR CAGR